After a Good Second Quarter Gerresheimer Raises its Revenue Forecast Again
2 Pages
English

After a Good Second Quarter Gerresheimer Raises its Revenue Forecast Again

Downloading requires you to have access to the YouScribe library
Learn all about the services we offer

Description

After a Good Second Quarter Gerresheimer Raises its Revenue Forecast Again PR Newswire DÜSSELDORF, Germany, July 11, 2012 DÜSSELDORF, Germany, July 11, 2012 /PRNewswire/ -- Group revenues rise 10.3 percent to EUR 314.0m in Q2 2012 Adjusted EBITDA increases by 4.3 percent to EUR 58.6m Net income rises to EUR 17.4m and EPS to EUR 0.51 Revenue forecast raised from 7 to 8 percent to 9 to 10 percent at constant exchange rates Expected investment volume rises from around EUR 100m to around EUR 120m The robust revenue growth trend continues at Gerresheimer AG, one of the world's leading partners of the pharma and healthcare industry. "Our revenues continued to develop very positively in the second quarter of 2012. This growth is being achieved in the emerging markets with standard glass and plastic pharmaceutical packaging products and in the established markets with sophisticated products for drug dosage and administration. Since we expect the growth trend to continue in the second six months of the year, we increase our revenue forecast for 2012 again and are planning substantial investments in these growth markets," said Uwe Röhrhoff, CEO of Gerresheimer AG. Gerresheimer has experienced above average growth in revenues in the second quarter of the 2012 financial year (December 1, 2011 to November 30, 2012) of 10.3 percent to EUR 314.0m. At constant exchange rates growth in revenues was 8.1 percent. All divisions contributed to this positive development.

Subjects

Informations

Published by
Reads 21
Language English
After a Good Second Quarter Gerresheimer
Raises its Revenue Forecast Again
PR Newswire
DÜSSELDORF, Germany, July 11, 2012
DÜSSELDORF,
Germany
,
July 11, 2012
/PRNewswire/ --
Group revenues rise 10.3 percent to
EUR 314.0m
in Q2 2012
Adjusted EBITDA increases by 4.3 percent to
EUR 58.6m
Net income rises to
EUR 17.4m
and EPS to
EUR 0.51
Revenue forecast raised from 7 to 8 percent to 9 to 10 percent at constant
exchange rates
Expected investment volume rises from around
EUR 100m
to around
EUR 120m
The robust revenue growth trend continues at Gerresheimer AG, one
of the world's leading partners of the pharma and healthcare
industry. "Our revenues continued to develop very positively in the
second quarter of 2012. This growth is being achieved in the emerging
markets with standard glass and plastic pharmaceutical packaging
products and in the established markets with sophisticated products
for drug dosage and administration. Since we expect the growth trend
to continue in the second six months of the year, we increase our
revenue forecast for 2012 again and are planning substantial
investments in these growth markets," said Uwe Röhrhoff, CEO of
Gerresheimer AG.
Gerresheimer has experienced above average growth in revenues in the
second quarter of the 2012 financial year (
December 1, 2011
to
November 30,
2012
) of 10.3 percent to
EUR 314.0m
. At constant exchange rates growth in
revenues was 8.1 percent. All divisions contributed to this positive development.
South America
was one of the strongest regions. Here growth in revenues from
plastic containers for tablets, powders, eye drops, nose sprays and other liquid
drugs was exceptionally high. Our business with medical plastic systems, such
as insulin pen systems and diagnostic instruments, also delivered very solid
results. Demand for pre-fillable glass syringes has also developed positively.
Revenues from engineering and tools for our product pipeline also made a
positive impact on revenue.
Gerresheimer's adjusted EBITDA was
EUR 58.6m
in the second quarter of 2012,
which is 4.3 percent higher than the prior year figure. The adjusted EBITDA
margin was 18.7 percent in the second quarter (prior year 19.8 percent). Net
income after tax increased to
EUR 17.4m
, which is
EUR 4.1m
higher than the
prior quarter figure. Second quarter earnings per share of
EUR 0.51
were
EUR
0.13
higher than one year ago.
"Our medical plastic systems order book and project pipeline are looking very
good at the moment and we will continue to increase our production capacity in
this segment. New production facilities are already being constructed at our
plants in Pfreimd in
Germany
and in Horsovsky Tyn in the
Czech Republic
. And
we are already planning the next-but-one extension of our Czech production
facility. We will also be investing in our new pharmaceutical glass container
plant in
India
over the coming months. I'm confident that the groundwork we
are laying today will take us forward into a very positive future," commented
Uwe Röhrhoff.
Outlook
In light of the sustained positive development of our business operations and
the positive outlook, particularly in the Plastic Systems and Tubular Glass
divisions, Gerresheimer is now expecting revenue growth of 9 to 10 percent in
the 2012 financial year, assuming that the exchange rates remain constant.
This is an upward revision by two percentage points. The company's operating
margin (adjusted EBITDA margin) forecast is still 19.5 percent. A high order
volume in the Plastic Systems division led to the company's decision to increase
its 2012 investment budget from approximately
EUR 100m
to around
EUR
120m
.
Cross reference: The press release including tables is available at:
http://ots.de/AyUB2
You can read the online annual report at:
http://annualreport2011.gerresheimer.com
Gerresheimer AG
Benrather Strasse 18 - 20
40213 Düsseldorf
Germany
Jens Kürten
Director Corporate Communication & Marketing
Telephone +49-211-6181-250
Fax
+49-211-6181-241
E-Mail
j.kuerten@gerresheimer.com
Internet http://www.gerresheimer.com